Lucie Andrés Cerezo

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 4

Top Topics

Disease Activity

Mesenchymal Stem Cells

Rheumatoid Arthritis

Top Venues

Rheumatology international

Arthritis research & therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Adéla Navrátilová, Viktor Bečvář, Hana Hulejová, Michal Tomcik, Lucie Štolová, Heřman Mann, Olga Růžičková, Olga Šléglová, Jakub Závada, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Lucie Andrés Cerezo
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis. RMD open 9 (2) (2023)
Adéla Navrátilová, Viktor Bečvář, Hana Hulejová, Michal Tomcik, Lucie Štolová, Heřman Mann, Olga Růžičková, Olga Šléglová, Jakub Závada, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt, Lucie Andrés Cerezo
New pro-inflammatory cytokine IL-40 is produced by activated neutrophils and plays a role in the early stages of seropositive rheumatoid arthritis. RMD open 9 (2) (2023)
Barbora Šumová, Lucie Andrés Cerezo, Lenka Szczuková, Lucie Nekvindová, Michal Uher, Hana Hulejová, Radka Moravcová, Mariam Grigorian, Karel Pavelka, Jiri Vencovsky, Ladislav Senolt, Jakub Závada
Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study. Rheumatology international 39 (3) (2018)
Lucie Andrés Cerezo, Barbora Šumová, Klára Prajzlerová, David Veigl, Dres Damgaard, Claus Henrik Nielsen, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt
Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis. Arthritis research & therapy 19 (1) (2017)